NHS Failing Fibromyalgia Sufferers, Study Finds

A comprehensive UK study has exposed critical shortcomings in how the National Health Service (NHS) manages fibromyalgia. The research indicates that diagnosis is often inconsistent and significantly delayed, particularly for male patients. Following diagnosis, available support is minimal, with many patients expressing dissatisfaction with the care they receive.

The investigation highlighted a lack of a consistent care model across the NHS. Patients reported extensive personal costs and difficulties navigating the healthcare system, often being referred between multiple specialists. This journey frequently leads to poor outcomes for their working lives and a sense of frustration.

Contrary to patient preferences for personalized, holistic, and non-drug support, medication remains the default treatment. Researchers noted that many clinicians hold unhelpful attitudes, some even doubting the condition's existence, leading to dismissive remarks about patients being distressed or lazy.